TOGETHER, WE KNOW IBD.
The We Know IBD Program is uniting doctors and patients
around the world to help advance IBD research.
The We Know IBD Program is a collection of clinical research studies evaluating an investigational medication for inflammatory bowel disease (IBD), including Crohn's disease (CD) & ulcerative colitis (UC). Those diagnosed with moderately to severely active CD or UC may be eligible to participate.
We Know IBD—and we know that additional treatment options start with clinical research.
Together, with leading doctors, nurses, and patients around the world, we’re working to advance the science of IBD treatment so that one day, long-lasting remission may be a possibility for more people living with IBD.
Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), causes chronic inflammation in the gastrointestinal tract.1, 2 Symptoms may include abdominal pain, diarrhea, and urgent bowel movements.3
REFERENCES
Studies in this program
Below are the clinical studies currently being conducted in our research program, focusing on investigational medications for inflammatory bowel disease, including Crohn's disease (CD) and ulcerative colitis (UC).
ICONIC-CD
ICONIC-UC
Clinical research studies test the safety and efficacy of an investigational medication (one not yet approved by a regulatory agency) in a group of people. This is the only way to find new or better treatment options.
By taking part in a clinical research study, you may:
- Get actively involved in your own healthcare
- Help others by progressing medical research
Contact us
Answer the following questions to see if you or someone you know may be eligible to take part in an ICONIC IBD study.
Please keep in mind:
Even if you believe you meet the eligibility criteria, joining a clinical trial is not guaranteed. Whether you’re referred or able to take part depends on a review by a qualified healthcare professional. This questionnaire is intended for United States participants only.
About your information:
With your consent, we will use your answers to help determine whether you may be eligible for this clinical trial. You can withdraw your consent at any time.
Your information may be transferred to countries outside your country of residence, including the United States, which may have different data protection rules.
If you submit any personal information about someone else, you confirm that you have permission to do so.
Please read our Privacy policy for more details.